论文部分内容阅读
目的:探讨苏子降气汤合三子养亲汤治疗痰浊型慢性阻塞性肺疾病的临床效果.方法:选取160例痰浊型慢性阻塞性肺疾病患者随机分为治疗组和对照组,治疗组给予中西医联合治疗,对照组仅给予西药治疗,比较两组患者临床疗效、治疗前后呼气峰流速测定值、肺功能指标.结果:治疗组和对照组临床疗效总有效率分别为93.75％和85.00％,治疗组患者临床控制率为52.50％,对照组患者临床控制率仅为85.00％,治疗后两组患者呼气峰流速测定值均显著提高,且治疗后治疗组患者呼气峰流速测定值提高更显著,治疗后两组患者FVC、FEV1及FEV1/FVC指标水平均显著提高,且治疗后治疗组患者FVC、FEV1及FEV1/FVC指标水平提高更显著,差异均具有统计学意义(P＜0.05).结论:苏子降气汤合三子养亲汤治疗痰浊型慢性阻塞性肺疾病,患者的临床疗效显著提高,改善患者的肺通气,安全性高,可以在临床上广泛推广.“,”Objective:To investigate the clinical effect of Suzi Jiangqi Decoction and Sanzi Yangqin Decoction in the treatment of phlegm-turbidity type chronic obstructive pulmonary disease.Methods:Selected 160 patients with chronic obstructive pulmonary disease and divided them into treatment group and controlled group randomly:The treatment group was treated with traditional Chinese medicine and western medicine.The controlled group was treated with western medicine only.To compare the clinical efficacy,before and after treatment peak expiratory flow rate,pulmonary function indicators of the two groups of patients.Results:The total effective rate of clinical efficacy was 93.75％ and 85.00％ in the treatment group and the controlled group respectively.The clinical control rate was 52.50％ in the treatment group and 85.00％ in the controlled group.After the treatment,the levels of FVC,FEV1 and FEV1/FVC were significantly increased in the two groups,and the levels of FVC,FEV1 and FEV1were significantly improved after treatment,and the levels of FVC,FEV1 and FEV1/FVC were more significantly improved in the treatment group,the difference was statistically significant (P＜0.05).Conclusion:It is effective of using Suzi Jiangqi Decoction combined with Sanzi Yangzi Decoction in the treatment of phlegm-turbidity type chronic obstructive pulmonary disease.The clinical efficacy of patients is significantly improved,and the pulmonary ventilation is improved and the safety is high.It can be widely used in clinic.